U.S. Markets close in 4 hrs 22 mins

AmeriCann, Inc. (ACAN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.3100-0.0900 (-6.43%)
As of 11:09AM EDT. Market open.

AmeriCann, Inc.

1555 Blake Street
Unit 502
Denver, CO 80202
United States
303 862 9000

Sector(s)Real Estate
IndustryReal Estate Services
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy Ryan KeoghCEO, Pres & Director180kN/A1980
Mr. Benjamin J. BartonFounder, Chief Financial & Accounting Officer and Director180kN/A1965
Dr. Rien Havens Ph.D.Extraction & Infused Product Advisor and Member of Advisory BoardN/AN/AN/A
Mr. Eric ForingtonGenetics & Breeding Advisor and Member of Advisory BoardN/AN/AN/A
Dr. D. Michael AndersonMedical Advisor & Member of Advisory BoardN/AN/AN/A
Mr. Nick BraitLicensing & Compliance Advisor and Member of Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


AmeriCann, Inc. operates as a specialized cannabis company in the United States. It intends to design, develop, lease, and operate cultivation, processing, and manufacturing facilities for licensed cannabis businesses in the United States. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was founded in 2010 and is based in Denver, Colorado.

Corporate Governance

AmeriCann, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.